首页> 外文OA文献 >Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

【2h】

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

机译：氟达拉滨/三硫磺调理方案的异基因造血干细胞移植与AML和MDS患者基于白消安的清髓和降低强度调理的比较；相对结果取决于SCT的疾病状况

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shimoni A.; Shem-Tov N.; Rand A.; Volchek Y.; Yerushalmi R.; Hardan I.; Nagler A.;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS). [J] . Kroger N, Shimoni A, Zabelina T, Bone marrow transplantation . 2006,第4期

机译：在患有继发性急性髓样白血病（sAML）或骨髓增生异常综合征（MDS）的老年患者中，以硫代硫丹，氟达拉滨和ATG作为同种异体干细胞移植（alloSCT）的制备方案，降低毒性。
2. Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT) [J] . LeBourgeoisA., LestangE., GuillaumeT., European Journal of Haematology . 2013,第3期

机译：氟达拉滨，静脉注射白消安和抗胸腺细胞球蛋白（FB2方案）前后的免疫状态和造血恢复对预后的影响-异体干细胞移植（allo-SCT）降低强度调节方案（RIC）
3. Is Busulfan and Fludarabine an Optimal Myeloablative Hematopoietic Stem Cell Transplant (HSCT) Conditioning Regimen in Children with AML/MDS ? [J] . Ramzan Mohammed, Ali Muhammad, Krueger Joerg, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：白消安和氟达拉滨是否是AML / MDS儿童的最佳清髓造血干细胞移植（HSCT）条件疗法？
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Dyadic predictors of psychosocial distress in patients undergoing autologous hematopoietic stem cell transplant (HSCT). [D] . Geller, Jessica B. 2016

机译：自体造血干细胞移植（HSCT）患者心理社会困扰的二元预测因子。
6. Experience with Alemtuzumab Fludarabine and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease Stem Cell Source and Alemtuzumab Regimen [O] . Rebecca A. Marsh, Marepalli B. Rao, Aharon Gefen, -1

机译：在非恶性疾病患者中使用Alemtuzumab氟达拉滨和美法仑降低强度的条件进行造血细胞移植的经验显示出良好的结果并且混合嵌合体的风险取决于基础疾病干细胞来源和Alemtuzumab方案
7. Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen [O] . Alatrash G., Andersson B., Pelosini M., 2009

机译：异基因造血干细胞移植（HSCT），用于使用AML或MDS进行清髓，降低毒性的白消安/氟达拉滨（BuFlu）调理方案治疗6到7岁的AML或MDS患者

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

著录项

引文网络

相似文献

相关主题

期刊订阅